AJAlma Jukic

Alma Jukic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alma Jukic has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Simultaneous Cochlear Implantation and Labyrinthine Surgery for Meniere Disease: Endolymphatic Sac Decompression Versus Labyrinthectomy

    by Alma Jukic, Hunter L. Elms, Ashton Huppert Steed, Trent House, Nancy Flores, Marine Cismas, Rick F. Nelson, Shawn M. Stevens

    Introduction: Patients with medically refractory Meniére disease (MD) may present with concomitant vertigo attacks and severe-profound hearing loss (SNHL). In such cases, simultaneous labyrinthectomy/cochlear implantation (CI) is a viable treatment option. Simultaneous endolymphatic sac decompression (ESD) and CI is less well described but represents a promising alternative. This study aims to analyze outcomes after simultaneous or staged ESD/CI as compared with simultaneous labyrinthectomy/CI. Materials and methods: MD patients undergoing simultaneous or staged ESD/CI and simultaneous labyrinthectomy/CI were reviewed from 2 tertiary care centers. Inclusion criteria included: ≥ 2 vertigo attacks/week, supportive vestibular testing, normal MRI, SNHL meeting criteria for CI, and average sodium intake of 1200 to 1500 mg/day. Demographic data, surgical complications, audiometric outcomes, and vestibular outcomes were analyzed. Results: Eighteen patients (19 ears) were included. Six patients (7 ears) underwent either simultaneous or staged ESD/CI, and 12 patients (12 ears) underwent labyrinthectomy/CI. Vertigo attacks decreased in 71.4% of ESD/CI patients and 100% of labyrinthectomy/CI patients. 6/7 ears in the ESD/CI cohort had improved AzBio sentence scores with an average improvement of 85.6% in quiet, 64.8% in +10 SNR, ( P P P <0.05) at the most recent follow-up. Conclusions: Simultaneous ESD/CI was safe and effective. Vestibular and hearing outcomes after this approach were comparable to those associated with labyrinthectomy/CI. ESD/CI may be associated with a lower rate of vertigo resolution than labyrinthectomy/CI. Level of Evidence: Level IV, retrospective case series.

  • Secondary Synostosis After Spring-Mediated Cranioplasty for Sagittal Synostosis

    by Max Shrout, Trey D. Watmore, Alma Jukic, Davinder J. Singh

    Objective: To evaluate the incidence and characteristics of secondary synostosis following spring-mediated cranioplasty (SMC) for nonsyndromic sagittal craniosynostosis. Design: Retrospective cohort study. Setting: Single tertiary pediatric hospital. Patients/Participants: Ten patients with isolated sagittal craniosynostosis who underwent primary SMC between 2021 and 2023. Patients with syndromic diagnoses or prior cranial surgery were excluded. Interventions: SMC was performed using 2 to 3 stainless-steel springs following sagittal strip craniectomy. Springs were typically removed 3 to 4 months postoperatively. Follow-up included review of clinical photographs, radiographs, and operative records. Main Outcome Measures: Change in cephalic index (CI) from preoperative to postoperative assessment and occurrence of secondary suture fusion, particularly coronal synostosis. Results: Mean age at surgery was 4 months (range, 3-6 months). Mean CI improved from 68.5 to 79 following expansion. Three patients (30%) developed left unicoronal synostosis (UCS) during the perioperative period prior to spring removal. One patient required secondary coronal suturectomy for significant frontal asymmetry, while 2 were observed without intervention. Conclusions: Secondary synostosis, particularly UCS, may represent an underrecognized sequela of SMC. Altered biomechanical forces or asymmetric cranial remodeling during distraction may contribute to this finding. Larger, multicenter studies with longitudinal imaging are warranted to determine incidence, risk factors, and preventive strategies.

  • How I Do It: A Novel, Single‐Stage Technique for BAHA to Osia Conversions

    by Alma Jukic, Ashton Huppert Steed, Trent House, Marine Prevost, Nancy Flores, Shawn M. Stevens

  • Sociodemographic Factors Associated with Late Presentation in Nonsyndromic Sagittal Synostosis

    by Trey D. Watmore, Alma Jukic, Santana S. Solomon, Haley A. Kenner, M’HAmed Temkit, Davinder J. Singh

    Objective: Our objective is to examine which sociodemographic factors may influence the time of presentation of patients with craniosynostosis, which can impact perioperative outcomes. Design: Retrospective cohort study. Setting: Tertiary pediatric hospital. Patients, Participants: All patients with nonsyndromic sagittal synostosis who underwent surgery at a tertiary pediatric hospital from January 1, 2007 to January 2, 2024 were eligible for inclusion. Interventions: Comparing demographic variables between those undergoing early and late craniosynostosis repair. Main Outcome Measure(s): Demographic variables, social vulnerability index (SVI) and area deprivation index (ADI), median household income, education rate, and employment rates. Results: 77.5% (n = 234) of patients underwent minimally invasive repair. 22.5% (n = 68) underwent open cranial vault remodeling. Age at consultation differed significantly between those undergoing early repair compared to late repair (0.18 years v. 1.01 years, P < .0001). Patients undergoing late repair were more likely to be Hispanic (42.6% v. 24.4%, P = .0378), on public insurance (66.2% v. 45.3%, P = .0079), have lower parental education rates (24.78% vs. 31.64%, P = .0019), and lower median household income ($65 657 vs. $75 281, P = .0226). Interestingly, ADI scores and SVI scores did not significantly differ between groups. Conclusions: Patients who presented later for treatment of nonsyndromic sagittal synostosis had lower median household income, were more likely to be Hispanic, had lower parental education rates, and were more likely to be on public insurance compared to those who received early treatment.

  • A Systematic Review of Surgical Characteristics and Adverse Events of an Active, Transcutaneous Bone Conduction Device

    by Alma Jukic, Christopher C. Munhall, Shawn M. Stevens

    Objective: A new, active transcutaneous bone conduction device (BCD) was FDA-approved in 2019 in the USA. This systematic review sought to evaluate early outcomes associated with Osia implantation. Methods: A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Four databases were reviewed: PubMed, Scopus, Cochrane CENTRAL, and CINAHL. Studies were included if they described audiometric, surgical characteristics/complications, or adverse events associated with the Osia BCD. Exclusion criteria: non-English language studies, animal investigations, reviews/meta-analyses, case reports, database studies. Results: Eighteen studies with 336 patients were included. Mean age at implantation was 37.9 years. About 79.5% of patients had MHL/CHL and 19.5% had SSD/SHL. Mean operative time was 71.6 minutes. Mean PTA gain from unaided conditions was 35.4 dB. Mean functional gain at high frequency (6 kHz and above) from aided conditions was 16.1 dB. Mean improvement in speech recognition thresholds was 19.1 dB from unaided conditions. Adverse events (all types) were reported in 20.1% of cases. Across all studies, the postoperative infection rate was 5%. About 2% of patients reported magnet retention issues. About 1.65% of cases were complicated by hematomas. Conclusions: Under systematic literature review, the Osia BCD has been associated with low complication rates, relatively short operative times, and good audiometric and speech outcomes, notably high frequency gain >6 kHz. More advanced audiometric outcome reporting remains limited and audiometric data and patient reported outcome measures were reported heterogeneously.


  • Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study

    by Alma Jukic, Marine Cismas, Nancy Flores, Shawn M. Stevens

    Objective: The purpose of this study was to review patient demographics, indications, intraoperative findings, complications/adverse events, and audiological outcomes related to the implantation of the Osia 2 device.Study Design: Retrospective case series.Setting: Single tertiary institutional experience.Methods: Patients who had undergone Osia 2 implantation by the senior author were identified from 2019 to present. Information was extracted from patient charts concerning patient demographics, indications for implantation, surgical findings, audiological outcomes, and adverse events.Results: Sixty patients and 67 implants were included. The median age was 51 years (R: 11‐92). Fifty‐five percent of patients had mixed hearing loss (HL), 30% had single‐sided deafness, and 15% had conductive HL. The mean operative time was 53.9 minutes. Only 4.5% of patients required bone polishing, and 3.0% required tissue thinning. The mean pure‐tone averages 4 gain from unaided conditions was 41.2 dB. Mean gain at 6 and 8 kHz from unaided conditions was 35.42 and 40.67 dB, respectively. Mean improvement in speech recognition threshold and word recognition score was significant in noise and quiet conditions. The all‐cause adverse event/complication rate in our series was 10.4%. The most common complications were infections (4.5%) and poorly controlled postoperative pain (3.0%). Hematomas occurred in 1.5% of patients. Reoperation was required in 4 patients; explant in 1.Conclusion: Use of the Osia 2 device in our series has resulted in good hearing outcomes, particularly in terms of high frequency gain. Complication rates were low. To our knowledge, this is the largest study to date reporting on Osia 2 outcomes.


  • Maternal and neonatal factors associated with cesarean delivery in a cohort of pregnancies complicated by prenatally diagnosed congenital heart disease

    by Heather Masters, Elisa Marcuccio, Alma Jukic, James Cnota, Sammy Tabbah, Allison Divanovic

    Background Pregnancies with prenatally diagnosed congenital heart disease (CHD) have increased cesarean delivery (CD) rates, with no outcome improvement. Objective We aim to examine indications for delivery, indications for CD and risk factors associated with CD. Study design Retrospective cohort of 322 singleton pregnancies prenatally diagnosed with moderate to severe CHD. We compared maternal and fetal factors correlated with delivery route. Results CD rate was 46% (95% CI 40, 51%). Of all CD, 31.3% (95% CI 23.8, 38.7) were secondary to urgent fetal indications. However, 79.7% of inductions resulted in vaginal delivery (VD). Factors associated with CD include morbid obesity (RR 3.0, 95% CI 1.5, 6.1), diabetes (RR 3.9, 95% CI 2.0, 7.3) and severe pre-eclampsia (6.0, 95% CI 1.7, 21.4). Of the 10 most frequent CHD diagnoses, only hypoplastic-left-heart was associated with CD (OR 1.9, 95% CI 1.02, 3.4). Conclusions Although the CD rate is higher in fetal CHD, most indications for CD are maternal.


  • Open Access

    Maternal and neonatal factors associated with cesarean delivery in a cohort of pregnancies complicated by prenatally diagnosed congenital heart disease

    by Heather Masters, Elisa Marcuccio, Alma Jukic, James Cnota, Sammy Tabbah, Allison Divanovic

    Background: Pregnancies with prenatally diagnosed congenital heart disease (CHD) have increased cesarean delivery (CD) rates, with no outcome improvement. Objective: We aim to examine indications for delivery, indications for CD and risk factors associated with CD. Study Design: Retrospective cohort of 322 singleton pregnancies prenatally diagnosed with moderate to severe CHD. We compared maternal and fetal factors correlated with delivery route. Results:CD rate was 46% (95%CI 40, 51%). Of all CD, 31.3% (95%CI 23.8, 38.7) were secondary to urgent fetal indications. However, 79.7% of inductions resulted in vaginal delivery (VD). Factors associated with CD include morbid obesity (RR 3.0, 95%CI 1.5, 6.1), diabetes (RR 3.9, 95%CI 2.0, 7.3) and severe pre-eclampsia (6.0, 95%CI 1.7, 21.4). Of the 10 most frequent CHD diagnoses, only hypoplastic-left-heart was associated with CD (OR 1.9, 95%CI 1.02, 3.4). Conclusions: Although the CD rate is higher in fetal CHD, most indications for CD are maternal.